Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
>200 µM
Hemolytic
Cytotoxic
50% Hemolysis | >200 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Antimicrobial Peptides for Topical Treatment of Osteomyelitis and Implant-Related Infections: Study in the Spongy Bone. | Pharmaceuticals (Basel) | 2018